Liver transplantation for the Budd-Chiari syndrome

Glenn Halff, Satoru Todo, Andreas G. Tzakis, Robert D. Gordon, Thomas E. Starzl

Research output: Contribution to journalArticlepeer-review

169 Scopus citations


A retrospective study was performed that analyzed 23 patients who had an orthotopic liver transplantation for the Budd-Chiari syndrome with end-stage liver disease. Patient follow-up was as long as 14 years. The technical considerations relevant to the Budd-Chiari syndrome were discussed. There have been no serious complications of postoperative anticoagulation. Three patients, all of whom died, had recurrence of the Budd-Chiari syndrome. No other patient has had evidence of recurrent Budd-Chiari syndrome on postoperative liver biopsies. One-, 3-, and 5-year actuarial survival was 68.8%, 44.7%, and 44.7%, respectively. It was concluded that orthotopic liver transplantation is the most effective treatment for patients with the Budd-Chiari syndrome and end-stage liver disease.

Original languageEnglish (US)
Pages (from-to)43-49
Number of pages7
JournalAnnals of surgery
Issue number1
StatePublished - 1990
Externally publishedYes

ASJC Scopus subject areas

  • Surgery


Dive into the research topics of 'Liver transplantation for the Budd-Chiari syndrome'. Together they form a unique fingerprint.

Cite this